Clinical trial
FREE Study: Efficacy and Toxicity of Trizivir
NCT00405925 · Rijnstate Hospital, Other · Completed
Key facts
| NCT number | NCT00405925 |
|---|---|
| Title | FREE Study: Efficacy and Toxicity of Trizivir |
| Official title | Free Study: a Randomised, Open Label, Multicentre Strategic Study to Evaluate the Efficacy and Toxicity of an Early Switch From a PI-containing Regimen to Trizivir ® on Guidance of Viral Load in HIV-1 Infected , Antiretroviral naïve Adults |
| Lead sponsor | Rijnstate Hospital, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Trizivir, zidovudine, lamivudine, abacavir |
| Enrollment | 207 |
| Start date | Mar 1, 2003 |
| Primary completion | Aug 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Nov 30, 2006 |
| Last update posted | Jun 2, 2010 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: